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Abstract
Objective: A review is made of the publications on bone regeneration using particulate grafts, with an evaluation 
of the success of implants placed in such regenerated areas.
Material and Method: A Medline search using different key words was made of the articles published between 
1999-2009 involving at least two patients subjected to grafting with autologous, homologous or xenogenic bone, 
non-bony substitutes, or a combination of these grafts for the placement of dental implants. Studies involving 
block grafting were excluded. A total of 11 studies were evaluated.
Results: These grafts are indicated in cases of small or peri-implant bone defects such as dehiscences and fenestra-
tions, with the possibility of combining a barrier membrane. However, some authors have used particulate block 
grafts to secure vertical or horizontal increments of the alveolar process. In most of these cases, graft healing until 
implant placement lasted 6-9 months. The most frequent complications in the receptor zone were wound dehis-
cences with exposure of the membrane. In almost all cases, prosthetic loading of the implants took place more than 
three months after their placement. The implant survival rate varied from 90.9% to 100%, with an implantation 
success rate of 85.7% to 100%.
Conclusions: Although our sample is small, due to the difficulty of finding homogeneous studies, it can be con-
cluded that particulate grafts are effective in correcting localized defects of the alveolar process. The complica-
tions of particulate grafting are few, and the success rate of implants placed in the reconstructed areas varies from 
85.7% to 100%.
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Introduction
An adequate bone volume is needed in order to guaran-
tee the long-term success of dental implant placement 
(1,2). A range of factors such as dental infections, alveo-
lar traumatisms, extractions or periodontal disease can 
give rise to localized or generalized bone defects of the 
alveolar process (3-5). In this context, bone grafts are 
an option for securing adequate bone volume and mor-
phology (6,7). Particulate grafts have been used in cases 
of small or peri-implant defects such as dehiscences 
and fenestrations, and combination with guided bone 
regeneration (GBR) techniques is also possible (8-10). 
When the bone defect is moderate, some authors have 
used block cortico-cancellous bone in particulate form 
to secure vertical or horizontal increments of the alveo-
lar process (11-13). 
The present review examines the publications on bone 
regeneration using particulate grafts, and evaluates the 
results obtained, as well as the complications of the sur-
gical technique and the survival and success rates of the 
implants placed in these regenerated areas.
Material and Method
A Medline search was made of the articles published 
between January 1999 and July 2009 involving patients 
subjected to particulate bone grafting for the treatment 
of peri-implant defects or for alveolar crest augmenta-
tion with a view to dental implant placement. Only full-
text human clinical studies were considered. Studies 
involving block grafts were excluded.
The patients were required to present defects as a re-
sult of atrophy, trauma or periodontal disease. The peri-
implant defects, dehiscences and fenestrations, were 
required to have occurred at the time of implant place-
ment. We excluded those studies involving defects re-
sulting from tumor resection, congenital malformations 
or osteoradionecrosis, as well as dental defects, and 
those defects involving fenestrations and dehiscences 
caused by peri-implant disease, since the initial clinical 
situation would be different, and the results therefore 
would not be comparable.
The following key words were used in the Medline 
search: particulate bone graft; dental implants; autolo-
gous bone graft; bone graft materials; guided bone re-
generation. 
Articles were extracted from the following journals: 
Clinical Oral Implants Research; The International 
Journal of Oral and Maxillofacial Implants; Journal of 
Oral and Maxillofacial Surgery; Journal of Periodonto-
logy.
We identified 64 articles, of which 53 were excluded: in 
21 of these latter publications particulate grafting was 
not used to treat peri-implant defects or achieve alveolar 
crest augmentation; in 14 cases particulate grafting was 
combined with block grafting; in four cases the peri-
implant defects did not occur during implant placement; 
in 6 cases the full text was not available; and 8 publica-
tions were not human clinical studies. A total of 11 stud-
ies were thus finally evaluated (Table 1), with collection 
of the following data in each of them: year of publica-
tion, type of study, patient characteristics (inclusion/
exclusion), type of intervention, and results.
Results and Discussion
Indications of particulate grafts
Particulate grafts fundamentally have been used in 
cases of small or peri-implant bone defects such as de-
hiscences and fenestrations, with the possibility of as-
sociating guided bone regeneration techniques (8-10, 
14). However, when the bone defect is moderate, and 
the aim is to secure vertical or horizontal increments, 
some authors prefer block cortico-cancellous bone in 
particulate form, using the Tessier osseous microtome 
or bone mill (12,13). These grafts can be harvested from 
the chin, mandibular ramus, maxillary tuberosity or 
mandibular torus (9,12,13,15,16). Biocompatible mem-
branes in turn can be used to avoid dispersion of the 
particles (9,12,13,15,16). 
Brunel et al. (17) and Pieri et al. (16) do not use grafts in 
the following situations: smokers of over 10 cigarettes 
a day, severe liver or kidney disease, a history of head 
and neck radiotherapy, chemotherapy at the time of sur-
gery, uncontrolled diabetes, active periodontal disease 
in the residual dentition, inflammatory or autoimmune 
disorders of the oral mucosa, poor oral hygiene, patient 
failure to cooperate, and any other disease condition 
contraindicating oral surgery.
In all the evaluated studies grafts were placed in both 
males and females, with no differences according to 
gender. The age range of the patients was 11-82 years.
Surgical procedure
Five studies (10,12, 14-16) used a combination of 
autograft with xenograft, hydroxyapatite or homolo-
gous bone. In the remaining 8 studies a single type of 
graft was used: autologous bone (8,10,13,14), homolo-
gous bone (11,14), bovine bone (10,18,19) or hydroxya-
patite (17).
In two studies (13,15) the intraoral autologous grafts 
were obtained from the retromolar region, while in one 
publication the graft was harvested from the mandibu-
lar ramus (16). One study (12) used intraoral grafts from 
the chin, mandibular ramus, mandibular torus or maxil-
lary tuberosity, and extraoral grafts from the iliac crest 
or tibia. 
The surgical procedure used in the receptor zone was 
the same in all the examined studies in which vertical 
and/or horizontal alveolar crest augmentations were 
performed. A supracrestal incision with vertical relea-
sing incisions were carried out, followed by the raising 
of a full thickness flap. The cortical layer was perforated 
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with a round or fissure drill in order to favor blood sup-
ply to the new bone. The graft particles were adapted to 
the receptor bone and were covered with a membrane 
affixed with titanium microscrews. Horizontal incisions 
were made in the periosteum to allow tension-free clo-
sure, followed by suturing. For the treatment of fenes-
trations or dehiscences, full thickness flaps were raised 
and the particulate bone graft was compacted over the 
defect, with the possible combination of bioabsorbable 
membranes, and final suturing.
In order to avoid gingival epithelial cell and connective 
tissue invasion over the defect, guided bone regenera-
tion membranes were usually used. Barrier membranes 
were used in all the studies, with the exception of the 
publication by Block and Degen (11). These membranes 
were non-reabsorbable in 7 studies (8, 12-16, 18), and 
reabsorbable in three studies (10,17,19)
Postoperative treatment comprised antibiotics and sys-
temic antiinflammatory medication during 7 days, and 
0.1-0.2% chlorhexidine rinses. The sutures were re-
moved after 10-15 days.
Graft success, millimeters of bone gained and superfi-
cial reabsorption
None of the evaluated studies established well defined 
bone graft success criteria. Louis et al. (12), in a ret-
rospective study of 44 patients, recorded the complete 
loss of one graft, requiring repeat surgery. Their graft 
success rate was 96.8%. Hämmerle et al. (19) reported 
adequate bone volume in all their patients, except in 
one case where no bone increment was obtained during 
the graft healing phase. Their success rate was 91.6%. 
Trombelli et al. (13) and Simion et al. (15) achieved the 
bone volume needed for the posterior placement of im-
plants, with a 100% success rate.
Five studies presented data on the amount of bone gai-
ned after grafting (11,12,15,18,19). Hämmerle et al. (19) 
described a series of 12 patients with an initial horizontal 
crest defect of 3.2 mm. These authors used a xenograft 
(Bio-Oss®) with a reabsorbable membrane. After 9-10 
months, they recorded a crest width of 6.9 mm – the 
gain being statistically significant. Likewise, Block and 
Degen (11) studied the gain in width of crests measuring 
under 4 mm. Four months after allogenic bone graft-
ing, the crest width was seen to measure over 5 mm. In 
the vertical dimension, Simion et al. (15), and Canullo 
and Malagnino (2008) placed protruded implants 4-7 
mm from the alveolar crest and covered them with Bio-
Oss® and a non-reabsorbable membrane. These authors 
reported a statistically significant gain in vertical bone 
height of 3.8 ± 1.2 mm and 5.3 ± 1.9 mm, respective-
ly, after 6 and 8 months. In the vertical and horizontal 
dimensions, Louis et al. (12) published a study of 44 
patients treated with a combination of autologous bone 
and hydroxyapatite grafting together with application of 
a titanium membrane. They recorded a mean bone gain 
of 13.9 mm in the mandible and of 12.8 mm in the upper 
maxilla.
As regards superficial reabsorption of the particulate 
grafts, Simion et al. (15) and Canullo and Malagnino 
(18) reported an average absorption of 0.2±0.7 mm after 
6-9.5 months, in sites with intraoral autologous grafts 
covered with Bio-Oss® and a non-reabsorbable mem-
brane, and of 0.0±1.0 mm after 6-8 months with Bio-
Oss® and a non-reabsorbable membrane.
Healing time
In the studies describing vertical or horizontal incre-
ments with particulate grafts, the implants were placed 
in second step surgery, allowing a prior graft healing 
period of 6-9 months (11-13, 15-17, 19). The excep-
tion is represented by Simion et al. (15) and Canullo 
and Malagnino (18), who placed the implants and the 
grafts in the same surgical step. In relation to horizontal 
mandibular augmentation, Block and Degen (11) placed 
the implants after a four-month healing interval. In the 
studies involving dehiscences or fenestrations (8,10,14), 
the particulate grafts were placed with the implants 
in the same surgical step. In 5 studies (12,13,15,17,18) 
biopsies were obtained of the implant receptor bone at 
the end of the graft healing period, and the histological 
study confirmed an adequate bone structure for implant 
placement.
The implants are to be placed once primary stability has 
been assured. Although it is possible to place grafts and 
implants simultaneously, in those cases where important 
vertical or circumferential increments are required it is 
advisable to first perform bone regeneration of the alve-
olar crest (6). The recommendation is a minimum of 4-5 
mm of residual bone for graft and implant placement in 
a single surgical step (9). In 5 studies (8,10,14,15,18) the 
implants were placed at the same time as the grafts. Von 
Arx and Wallkamm (8), Blanco et al. (14) and Benić et 
al. (10) treated cases of dehiscences and fenestrations, 
while Simion et al. (15) and Canullo and Malagnino (18) 
treated patients with vertical crest defects. 
Complications
Receptor zone
In most cases graft healing and consolidation occurred 
without problems. In the study published by Louis et 
al. (12), 23 membranes were exposed during the heal-
ing phase (43.7% in the upper maxilla, and 55% in the 
mandible), and 7 of them were removed. Nevertheless, 
all but one of the patients maintained enough bone for 
implant placement. Brunel et al. (17) and Blanco et al. 
(14), with 14 and 26 graft sites, respectively, recorded 
6 and 3 membrane exposures during the graft healing 
phase, though in no case did removal prove necessary. 
Von Arx and Wallkamm (8) and Simion et al. (15), with 
20 and 10 graft sites, respectively, each reported a sin-
gle membrane exposure after three months, and both of 
them were removed.
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Donor zone
In the study published by Simion et al. (15), one patient 
reported altered lower lip sensitivity after autologous 
bone harvesting from the retromolar region. This prob-
lem disappeared one month after the operation, how-
ever. There were no other complications in the reviewed 
studies.
Time to prosthetic loading
In most cases, prosthetic loading occurred at least three 
months after implant placement (10,16,17). Pieri et al. 
(16) loaded the implants of the mandible after three 
months, and in the upper maxilla after four months. 
Brunel et al. (17) and Benić et al. (10) in turn performed 
loading after 6 months – the latter author performing 
loading after three months in the case of transmucosal 
implants.
Implant survival and success
The implant survival rate ranged from 90.9% to 100% 
in the different studies (10-18). 
As regards the success rate of the implants, not all the 
studies used well defined success criteria – thus making 
comparison difficult. Pieri et al. (16) based their data on 
the success criteria of Albrektsson (1986), with a suc-
cess rate of 93.2% two years after loading (85.7% in the 
upper maxilla and 100% in the mandible). Brunel et al. 
(17) in turn used the criteria of Cutter and Ederer, re-
porting a success rate of 85.7% three years after loading. 
Other authors (10-13,15) reported a 100% success rate, 
though without specifying concrete success criteria.
Conclusions
Although our sample is small, due to the difficulty of 
finding homogeneous studies, it can be concluded that 
particulate grafts are effective in correcting localized 
defects of the alveolar process. The complications of 
particulate grafting are few, and the success rate of 
implants placed in the reconstructed areas varies from 
85.7% to 100%.
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